Neuroinflammation has been implicated in the pathogenesis of neurodegenerative Parkinson's disease (PD). Moreover, some studies have found that total T cell pool was changed in PD. However, little is known about peripheral blood mononuclear cells (PBMC) in the pathogenesis of PD. Recent studies have demonstrated that endogenous neurotoxin 1,2(N)- dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (N-methyl-salsolinol, NMSal), an analogue of 1-methyl-4-phenyl-1,2, 3,6- tetrahydropyridine (MPTP) in the brain, could induce degeneration of dopaminergic neurons and cause neuroimmune dysfunction in PD. In the present study, we examined the effect of conditioned medium from NMSal treated co-cultures of neuroblastoma SH-SY5Y cells and glioma cell line U87 cells on human monocyte THP-1 cells. The results showed that the conditioned medium attenuated apoptosis of THP-1 cells mediated by NMSal. The conditioned medium inhibited the swelling and rupture of mitochondrial membrane, reduced the production of malondialdehyde (MDA) and H2O2, and decreased expression levels of caspase3, Bax and FADD of THP-1 cells induced by NMSal. These indicated that the interaction of neurons with astrocyte could affect cell amount and immune function of PBMC, then affecting the progression of PD.
WANG Fuli
,
DENG Yulin
. Attenuation of N-methyl-salsolinol mediated apoptosis of THP- 1 cells by the conditioned medium from co-cultures of SH-SY5Y and U87 cells[J]. Science & Technology Review, 2015
, 33(10)
: 107
-112
.
DOI: 10.3981/j.issn.1000-7857.2015.10.011
[1] Chen X, Arshad A, Qing H, et al. Enzymatic condensation of dopamine and acetaldehyde: A salsolinol synthase from rat brain [J]. Biologia, 2011, 66(6): 1183-1188.
[2] Labandeira-Garcia J L, Rodriguez-Perez A I, Villar-Cheda B, et al. Rho kinase and dopaminergic degeneration: A promising therapeutic targetforparkinson'sdisease[J].Neuroscientist,2014, 1073858414554954.
[3] Litvan I, Bhatia K P, Burn D J, et al. Movement disorders society scientific issues committee report: Sic task force appraisal of clinical diagnostic criteria for parkinsonian disorders[J]. Movement Disorder, 2003, 18(5): 467-486.
[4] Dauer W, Przedborski S. Parkinson's disease: Mechanisms and models[J]. Neuron, 2003, 39(6): 889-909.
[5] Langston J W, Ballard P, Tetrud J W, et al. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis[J]. Science, 1983, 219(4587): 979-980.
[6] Nicklas W J, Vyas I, Heikkila R E. Inhibition of nadh-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine[J]. Life Science, 1985, 36(26): 2503-2508.
[7] Brochard V, Combadiere B, Prigent A, et al. Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of parkinson disease[J]. Journal of Clinical Investigation, 2009, 119(1): 182-192.
[8] Calopa M, Bas J, Callen A, et al. Apoptosis of peripheral blood lymphocytes in parkinson patients[J]. Neurobiology of Disease, 2010, 38 (1): 1-7.
[9] Saunders R N, Metcalfe M S, Nicholson M L. Rapamycin in transplantation: A review of the evidence[J]. Kidney International, 2001, 59(1): 3-16.
[10] Pettit D A, Williamson J, Cabral G A, et al. In vitro destruction of nerve cell cultures by acanthamoeba spp: A transmission and scanning electron microscopy study[J]. Journal of Parasitol, 1996, 82(5): 769- 777.
[11] Funk N, Wieghofer P, Grimm S, et al. Characterization of peripheral hematopoietic stem cells and monocytes in parkinson's disease[J]. Movement Disorder, 2013, 28(3): 392-395.
[12] Deleidi M, Gasser T. The role of inflammation in sporadic and familial parkinson's disease[J]. Cellular and Molecular Life Sciences, 2013, 70 (22): 4259-4273.
[13] Naoi M, Maruyama W, Nagy G M. Dopamine-derived salsolinol derivatives as endogenous monoamine oxidase inhibitors: Occurrence, metabolism and function in human brains[J]. Neurotoxicology, 2004, 25 (1-2): 193-204.
[14] Mravec B. Salsolinol, a derivate of dopamine, is a possible modulator of catecholaminergic transmission: A review of recent developments[J]. Physiological Research, 2006, 55(4): 353-364.
[15] Deng Y, Luan Y, Qing H, et al. The formation of catechol isoquinolines in pc12 cells exposed to manganese[J]. Neuroscience Letters, 2008, 444(2): 122-126.
[16] Kroemer G, Dallaporta B, Resche-Rigon M. The mitochondrial death/ life regulator in apoptosis and necrosis[J]. Annual Review of Physiology, 1998, 60: 619-642.
[17] Maruyama W, Dostert P, Naoi M. Dopamine-derived 1-methyl-6,7- dihydroxyisoquinolines as hydroxyl radical promoters and scavengers in the rat brain: In vivo and in vitro studies[J]. Journal of Neurochemstry, 1995, 64(6): 2635-2643.
[18] Alnemri E S, Livingston D J, Nicholson D W, et al. Human ice/ced-3 protease nomenclature[J]. Cell, 1996, 87(2): 171.